We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting (CAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01617993
Recruitment Status : Completed
First Posted : June 13, 2012
Last Update Posted : January 13, 2014
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
User questionnaire of Eeva System usability and reports of device malfunctions.

Condition or disease
Infertility

Detailed Description:
This study is designed to evaluate the use of Eeva by IVF laboratory staff during routine procedures. The fertilized eggs will be placed in an Eeva dish and the development of the embryos will be monitored by the Eeva system in a standard incubator. On day 3 of embryo culture, Eeva blastocyst prediction data will be printed from the system to be used to assist the embryologist in selecting the best embryo(s). The performance of the system will be summarized and the user feedback from the embryologists will be collected.

Study Design

Study Type : Observational
Actual Enrollment : 31 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Eeva Continued Access Study.
Study Start Date : June 2012
Primary Completion Date : February 2013
Study Completion Date : February 2013
Groups and Cohorts

Group/Cohort
Women undergoing IVF treatment
Women undergoing IVF treatment


Outcome Measures

Primary Outcome Measures :
  1. User questionnaire of Eeva System usability and reports of device malfunctions. [ Time Frame: Participants will be followed through ongoing pregnancy, at approximately 10-12 weeks gestational age. ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women in the United States who undergo IVF treatment and imaging of their embryos with Eeva.
Criteria

Inclusion Criteria:

  • Women undergoing fresh in vitro fertilization treatment using their own eggs or donor eggs
  • Subject is ≥ 18 and ≤ 40 years of age.
  • Subject has basal antral follicle count (AFC) ≥ 8 prior to stimulation cycle.
  • Fertilization using only ejaculated sperm (fresh or frozen) - no surgically retrieved sperm.
  • Subject has ≥ 5 normally fertilized eggs (2 PN)
  • Willing to have all 2PN embryos monitored by Eeva
  • Willing to comply with study protocol and procedures and able to speak English.
  • Willing to provide written informed consent.

Exclusion Criteria:

  • Reinseminated eggs.
  • History of cancer.
  • Gestational carriers.
  • Planned preimplantation genetic diagnosis or preimplantation genetic screening.
  • Previously enrolled in this study
  • Concurrent participation in another clinical study.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01617993


Locations
United States, California
Pacific Fertility Center
San Francisco, California, United States, 94133
Fertility Physicians of Northern California
San Jose, California, United States, 95124
Reproductive Science Center
San Ramon, California, United States, 94583
Sponsors and Collaborators
Progyny, Inc.
Investigators
Study Director: Shehua Shen, ELD, MD Progyny, Inc.
More Information

Additional Information:
Responsible Party: Progyny, Inc.
ClinicalTrials.gov Identifier: NCT01617993     History of Changes
Other Study ID Numbers: 2012-AUX-002
First Posted: June 13, 2012    Key Record Dates
Last Update Posted: January 13, 2014
Last Verified: January 2014

Keywords provided by Progyny, Inc.:
in vitro fertilization
assisted reproduction
noninvasive imaging of embryos
time lapse imaging of embryos
traditional morphological grading of embryos
prediction of blastocysts
infertility
Genital Diseases, Male
Genital Diseases, Female

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female